FREE Case Review (866) 588-0600

Louisiana Mother Says Daughter’s Heart Defects Caused by Zofran

A Louisiana mother has filed a lawsuit against the manufacturer of Zofran alleging that the drug taken during her pregnancy is responsible for having caused severe heart defects in her unborn child.

A woman from Louisiana has filed a lawsuit against GlaxoSmithKline (GSK) alleging that the anti-nausea medication Zofran caused several life-threatening heart defects in her unborn child.

Free Confidential Zofran Lawsuit Evaluation: If your child was born with a heart defect, cleft palate, clubfoot or other birth defect, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the problem?


November 24, 2015 – According to the lawsuit, plaintiff was prescribed Zofran for morning sickness during her first trimester of pregnancy. Her daughter was born on July 15, 2010, and subsequently diagnosed with the following birth defects:

  • Perimembranous Ventricular Septal Defect (VSD) – Hole in the heart located in the membranous septum, a small part of the septum located near the heart valves.
  • Atrial Septal Defect (ASD) – Hole in the wall between the 2 upper chambers of the heart (atria).
  • Intermittent Tachypnea – Respiratory disorder seen shortly after delivery characterized by rapid breathing, bluish skin color (cyanosis), flaring nostrils and movements between the ribs or breastbone.

As a result of these problems, the child was forced to undergo corrective surgery shortly after birth.

The complaint alleges that because of these defects, both mother and daughter have suffered “severe and permanent pain and suffering, mental anguish, medical expenses, and other economic and non-economic damages.” Plaintiff stated that had she known about the risk associated with using Zofran during pregnancy, she never would have taken the drug and her daughter would have been born healthy.

The complaint was filed June 8, 2015, in the U.S. District Court for the Western District of Louisiana under case number 6:15-cv-01815-RFD-PJHm, and will be transferred to the recently-formed Zofran multidistrict litigation in Boston.

Litigation Status

Last month, numerous plaintiffs and GSK went before a panel of judges to request that all federally-filed Zofran lawsuits be consolidated into an multidistrict litigation (MDL) for pretrial handling. The panel agreed and MDL 2657 was centralized in the District of Massachusetts before Judge Dennis F. Saylor, IV.

A total of 12 cases were listed under Schedule A, and will be the 1st to be assigned to Saylor for coordinated pretrial proceedings. A Plaintiffs’ Steering Committee will then be appointed, which will review documents, take depositions, write briefs and assist plaintiffs by providing them with a trial package with all necessary documents.

Do I Have a Zofran Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Zofran lawsuits. We are handling individual litigation nationwide and currently accepting new birth defect cases in all 50 states.

Free Confidential Case Evaluation: Again, if your child or other loved one was injured by Zofran side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*

Awards & recognition